NASDAQ
bluebird bio, Inc. (BLUE) has a free cash flow growth of 12.53% as of Friday, May 29, 2026. This represents a 118.88% increase compared to its 12-month average of -66.40%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.